Search results
Author(s):
Laurent Roten
,
Matthew Daly
,
Patrizio Pascale
,
et al
Added:
3 years ago
With an ageing population and widespread use of implantable cardioverter-defibrillators, physicians are confronted with an increasing number of patients with symptomatic, drug-refractory ventricular tachycardia (VT). Catheter ablation is an important treatment option in the management of patients with structural heart disease and VT.1,2 In many patients, VT can be successfully ablated from the…
View more
Author(s):
Eduardo Back Sternick
,
Mariana Faustino
,
Frederico Soares Correa
,
et al
Added:
3 years ago
Radiofrequency (RF) catheter ablation is currently the treatment of choice in patients with accessory pathways (APs) and Wolff– Parkinson–White syndrome, and is shown to have a success rate >95 %.1 APs usually have endocardial ventricular and atrial insertions, located close to the atrioventricular valve rings, making most endocardial catheter ablation procedures relatively straightforward and…
View more
Author(s):
Thorsten Hanke, MD
Start date:
Nov 18, 2017
This live stream will be presented during the following session:
Session 9: Interesting and challenging cases
Case 4, presented by Thorsten Hanke, MD
Moderator: Lars Sondergaard, MD / Stefan Bertog, MD
Panelist: Bushra Rana, MD / Vijay Swarup, MD
View more
Author(s):
Mario Njeim
,
Frank Bogun
Added:
3 years ago
Percutaneous ablation for ventricular tachycardia (VT) was first attempted in 1983 and has rapidly evolved to become an important option for controlling recurrent VTs.1 Endocardial ablation remained the only percutaneous approach until epicardial access was introduced by Sosa et al. in 1996 and thereafter became progressively more available as an adjunctive strategy for the treatment of…
View more
Author(s):
Charles M Pearman
,
Shi S Poon
,
Laura J Bonnett
,
et al
Added:
3 years ago
The goal of arrhythmia eradication in AF continues to be elusive for cardiac electrophysiologists. Although endocardial radiofrequency (RF) catheter ablation is more effective than pharmacological management at maintaining sinus rhythm,1 it is far from perfect, especially in patients with non-paroxysmal AF.2 In an attempt to address this, attention has turned back to the surgical ablation that…
View more
Author(s):
Amit J Thosani
,
Paul Gerczuk
,
Emerson Liu
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide. In 2010, the prevalence of AF in the US was estimated at 5.9 million.1 The decision to pursue treatment to maintain sinus rhythm is driven by disabling symptoms related to AF; including palpitations, dyspnoea, fatigue, stroke and congestive heart failure. Percutaneous catheter-based ablation is an established therapy for…
View more
Author(s):
Mathieu Lebloa
,
Patrizio Pascale
Added:
1 year ago
Author(s):
Ramanan Kumareswaran
,
Francis E Marchlinski
Added:
3 years ago
Ventricular tachycardia (VT) is one of the most challenging medical conditions faced by cardiac patients and physicians treating them. Antiarrhythmic medications have limited effectiveness and are frequently poorly tolerated.1–4 Catheter ablation is increasingly used to treat patients successfully.1,5–7 Most VTs can be ablated endocardially but some require epicardial mapping and ablation…
View more
Convergent AF Ablation
Author(s):
Karan Wats
,
Andy Kiser
,
Kevin Makati
,
et al
Added:
3 years ago
Article
Author(s):
Adam J Graham
,
Richard Schilling
Added:
2 years ago